Taner DAŞ, Mehtap ÖZDEMİR, Murat Nihat ARSLAN, Semih YILDIRIM

Yüksek doz Olanzapin alımı ile birlikte tespit edilen venöz tromboembolinin beklenmeyen komplikasyonu: Pelviste doku içi kanama

Adli otopsiler sırasında zaman zaman karşılaşılabilen venöz tromboemboli[VTE] ciddi komplikasyonlarla önemli morbidite ve mortalitesebebi olmakla birlikte tanımlanmış pek çok risk faktörümevcuttur. Bu yazıda sunulan 51 yaşındaki kadın olguda yaygınpelvis içi yumuşak doku kanamasına neden olmuş VTE tespit edilmiştir.Son dönemlerinde psikolojik sorunlar yaşadığı öğrenilmişve otopside alınan örneklerinde yüksek düzeyde Olanzapin tespitedilmiştir. Birden fazla risk faktörünü barındıran, sonucunda dadoku içi kanama gibi beklenmeyen ve literatürde karşılaşılmayanbir komplikasyonla sonlanan bir VTE olgusu olması nedeniyle akademikortamda paylaşılarak tartışılmasının faydalı olacağı düşü-nülmüştür

Pelvic hemorrhage as an unexpected complication of venous thromboembolism due to high dose of Olanzapine intake

Venous thromboembolism [VTE]-a disease with high rates ofmorbidity and mortality due to serious complication- is associatedwith various risk factors. The article presents the caseof 51-year-old woman who was diagnosed with VTE causingextensive intrapelvic hemorrhage. Family anamnesis revealedthat the person has undergone psychological problems recentlyand accordingly, high intake of Olanzapine was detected throughthe samples taken in the autopsy. The VTE case is consideredto be relevant for further discussion on the academic platformas it involves more than one risk factors and pelvic hemorrhagewas encountered as unexpected and uncommon complication inthe literature.

PDF

___

1. Jönsson AK, Spigset 0, H'agg S. Venous thromboembolism in recipients of antipsychotics. CNS drugs 2012;26[8]:649--62.
2. De Hert M, Einfinger G, Scherpenberg E, Wampers M, Peu-- skens J. The prevention of deep venous thrombosis in physi-- cally restrained patients with schizophrenia. Int Clin Pract 2010;64[8]:1109--15.
3. Masopust J, Maly R, Urban A, Hosak L, Cermakovâ E. Anti-- psychotic drugs as risk factor for venous thromboembolism. Int Psychiat Clin 2007;1 [31:246--9.
4. Sheaff MT, DJ H. The Cardiovascular System. Post Mortem Technique Handbook. 2nd ed. London: Springer; 2005. p.153.
5. Lacut K, Le Gal G, Couturaud F, Cornily G, Leroyer C, Mottier D, et al. Association between antipsychotic drugs, antidepres-- sant drugs and venous thromboembolism: results from the EDITH case--control study. Fund Clin Pharm 2007;21[6]:643--50.
6. Maly R, Masopust J, Hosak L, Urban A. Four cases of venous thromboembolism associated with olanzapine. Psychiat Clin Neuros 2009;63[1]:116--8.
7. H'agg S, Spigset O. Antipsychotic--induced venous thrombo-- embolism. CNS drugs 2002;16[11]:765--76.
8. Masopust J, Maly R, Valis M. Risk of venous thromboembo-- lism during treatment with antipsychotic agents. Psychiat Clin Neuros 2012;66[7]:541--52.
9. Van Neste EG, Verbruggen W, Leysen M. Deep venous thrombosis and pulmonary embolism in psychiatric settings. Eur Psychiat 2009;23[1]:19--30.
10. Applebaum J, Shimon H, Sela B--A, Belmaker R, Levine J. Homocysteine levels in newly admitted schizophrenic patients. Journal of psychiatric research 2004;38[4]:413--6.
11. Winek CL, Wahba WW, Balzer TW. Drug and chemi-- cal blood--level data 2001. Forensic Science International 2001;122[2]:107--23.
12. Kooiman J, van Hagen N, del Sol AI, Planken EV, Lip GY, van der Meer FJ, et al. The HAS--BLED score identifies patients with acute venous thromboembolism at high risk of major bleeding complications during the first six months of antico-- agulant treatment. PloS one 2015;10[4]:e0122520. due to high dose of Olanzapine intake
13. Clark NP, Witt DM, Davies LE, Saito EM, McCool KH, Douketis JD, et al. Bleeding, recurrent venous thromboembo-- lism, and mortality risks during warfarin interruption for inva-- sive procedures. JAMA internal medicine 2015;175l7]:1163--8.
14. Sandén P, Renlund H, Svensson PJ, Sj'alander A. Bleed-- ing complications in venous thrombosis patients on well-- managed warfarin. Journal of thrombosis and thrombolysis 2016;41[2]:351--8.